PharmaBoardroom

Interview with Allan Marchington, Partner, Apposite Capital LLP

As a partner at Apposite since the company was created in 2006, what was the founding vision of the company and what do you consider have been its…

Interview with Keith Martin, CEO, Apitope

Apitope’s research and success is based on its High Speed Technology Platform that uses soluble peptides as vehicles to regulate immune responses in…

Interview with Rolf Ammelburg, General Manager, Roche Thailand

Dr Ammelburg, you have been working for Roche for more than 25 years now, time essentially spent between your home country Germany and Thailand. After…

Interview with Pankaj R. Patel , Chairman and Managing Director,…

You have very successfully executed a vision that you have had for the company since it was a 200 Rs Cr turnover, India-focused enterprise 15 years…

Interview with Andrew Giddy, CEO, Nucleus Network

Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research…

Interview with Rosa Maria Scavarelli, President, Theraskin Brazil

When we met you in 2007, as the head of the former Igefarma, the company was undergoing a transition – from branded generics into dermocosmetics…

Interview with Rogerio MANSUR, Director of Operations, DHL Life…

Rogerio, you were one of the people responsible for integrating two well-established companies in the Brazilian market with the acquisition of Exel by…

Interview with Mark Brown, Head of Tahiland/Vietnam Cluster,…

You are General Manager for Thailand and Vietnam; two markets that certainly interest companies but at a very different stage of development. What are…

Interview with Norbert Oppitz, Senior Vice President Latin…

Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this…

Interview with Mark Glover , Vice President and Managing…

How have PBS reforms impacted Allergan in Australia? The PBS is a very good system that provides Australians with equity of access and has worked well…

Interview with John Montgomery , CEO, Alphapharm

Alphapharm recently celebrated its 25th anniversary. In light of this significant milestone, would you give us a brief introduction to the company?…

Interview with Jez Moulding, General Manager, Sanofi Australia

What impact have the PBS reforms had on sanofi-aventis in Australia? Sanofi-aventis has one of the largest portfolios of medicines in Australia,…

Tagged with